Health Tech Capitol | Uncategorized
1
archive,paged,category,category-uncategorized,category-1,paged-42,category-paged-42,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Uncategorized

HealthMyne, a fast-growing Madison start-up that that provides analytics for medical images in cancer care, has raised $6.9 million of investments, according to a filing with federal securities regulators. The company, which lists among its co-founders the medical physicist who developed the technology behind TomoTherapy Inc., will use the...

Catalyze, Inc., healthcare’s leading HITRUST CSF Certified cloud provider, announced today that it has raised $6.5 million in a Series B fundraising effort. St. Louis-based Lewis & Clark Ventures led the round, with participation of existing investors, Arthur Ventures, Baird Venture Partners and Chicago Ventures....

MADISON, Wis., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) ("the company"), an oncology-focused biotechnology company, today announces that its lead therapeutic compound, CLR 131, currently in a Phase 1 clinical trial for multiple myeloma and preparing for a Phase 2 study in...

BioTechnique, a specialty drug aseptic fill-finish contract manufacturing organization, will launch a second phase of manufacturing in partnership with a major, international not-for-profit organization, the company announced recently. “We are very pleased to support a major non-profit trust in bringing their novel dosage form to market,” BioTechnique...